Insight Molecular Diagnostics Inc. Shareholders' Equity
Insight Molecular Diagnostics Inc. (IMDX) had Shareholders' Equity of -$21.30 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent -$21.30M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$10.69M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$31.46M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$9.20M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$21.30M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | -$10.69M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | -$31.46M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | -$9.20M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.10M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $10.22M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | -$12.27M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $9.71M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $22.70M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $11.59M 10-Q · filed 2025-08-11 | |
| 2023-12-31 | $20.47M 10-K · filed 2026-03-26 | |
| 2023-09-30 | $36.14M 10-Q · filed 2024-11-12 | $37.56M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $43.60M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $37.93M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $34.29M 10-K · filed 2025-03-24 | |
| 2022-09-30 | $76.86M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $83.24M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $56.97M 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $65.22M 10-K · filed 2024-04-16 | |
| 2021-09-30 | $99.35M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $102.67M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $106.63M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $33.48M 10-K · filed 2023-04-12 | |
| 2020-09-30 | $34.64M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $39.59M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $36.63M 10-Q · filed 2021-08-11 | |
| 2019-12-31 | $30.84M 10-K · filed 2022-03-11 | |
| 2019-09-30 | $29.34M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $33.51M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $38.19M 10-Q · filed 2020-07-29 | |
| 2018-12-31 | $3.42M 10-K · filed 2021-03-19 | |
| 2018-09-30 | $7.52M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $6.85M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $9.02M 10-Q · filed 2019-08-14 | |
| 2017-12-31 | $4.40M 10-K · filed 2020-03-26 | |
| 2017-09-30 | $8.05M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $5.64M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $8.77M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $9.86M 10-K · filed 2019-04-01 | |
| 2016-09-30 | $12.68M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $4.47M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $6.89M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $10.42M 10-K · filed 2018-04-02 | $10.15M 10-Q · filed 2016-05-16 |
| 2014-12-31 | -$1.07M 10-K · filed 2018-04-02 | |
| 2013-12-31 | $3.62M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |